Latest Breaking News On - J thorac cardiovasc - Page 2 : comparemela.com

Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting

Interim Data Demonstrate Meaningful Reduction of All-Cause Mortality with AMDS ATLANTA, Oct. 5, 2023 /PRNewswire/ Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic.

United statesFernando fleischmanBrian johnston lynn lewisJ thorac cardiovascD ashley leePat mackinDrug administrationEuropean association for cardioPrnewswire artivion incArtivion incGilmartin groupHealth canadaInterim data demonstrate meaningful reductionAll cause mortalityLate breaking scienceEuropean association

Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting

/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today presented interim results from the.

United statesFernando fleischmanBrian johnston lynn lewisJ thorac cardiovascD ashley leePat mackinDrug administrationEuropean association for cardioPrnewswire artivion incArtivion incGilmartin groupHealth canadaInterim data demonstrate meaningful reductionAll cause mortalityLate breaking scienceEuropean association

Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin

Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomColl cardiolJ thorac cardiovascBrian johnstonPat mackinLynn lewisD ashley leeInternational normalized ratioArtivion incEuropean association for cardioPrnewswire artivion incDrug administrationGilmartin groupLate breaking science presented

Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial

Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

J thorac cardiovascRegistry of the international society for heartPulmonary councilHealth technolInternational society for heartInternational societyLung transplantationHeart lung transplantDatabase syst revTechnol assessThorac surgThorac cardiovasc surgInternational thoracic organ transplant registry

LivaNova plc (LIVN) Unveils Essenz In-Line Blood Monitor with U S FDA 510(k) Clearance and CE Mark

LivaNova plc (LIVN) Unveils Essenz In-Line Blood Monitor with U S FDA 510(k) Clearance and CE Mark
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited arab emiratesHenri van heugtenMarloes van hoevenJ thorac cardiovascJoyce curversMarco dolciLivanovab captaBriana gotlinEddy overdevestJournal of extracorporeal technologyClinical laboratory improvement amendmentsDrug administrationIn line blood monitorEperfusion system